Deutsche Bank
PRAX icon

Deutsche Bank’s Praxis Precision Medicines PRAX Stock Holding History

Deutsche Bank’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.4M Buy
66,536
+2,273
+4% +$752K 0.01% 828
2026
Q2 		$21.5M Buy
64,263
+6,484
+11% +$2.05M 0.01% 838
2026
Q1 		$18.6M Buy
57,779
+6,968
+14% +$2.16M 0.01% 873
2025
Q4 		$15M Buy
50,811
+36,955
+267% +$6.88M ﹤0.01% 963
2025
Q3 		$734K Buy
13,856
+1,732
+14% +$84K ﹤0.01% 2344
2025
Q2 		$510K Sell
12,124
-1,737
-13% -$66.1K ﹤0.01% 2449
2025
Q1 		$525K Sell
13,861
-1,463
-10% -$91.4K ﹤0.01% 2472
2024
Q4 		$1.18M Buy
15,324
+5,009
+49% +$362K ﹤0.01% 2148
2024
Q3 		$594K Buy
10,315
+2,406
+30% +$130K ﹤0.01% 2367
2024
Q2 		$327K Buy
7,909
+7,757
+5,103% +$367K ﹤0.01% 2555
2024
Q1 		$9.28K Hold
152
– – ﹤0.01% 3535
2023
Q4 		$3.39K Sell
152
-1
-0.7% -$18 ﹤0.01% 3584
2023
Q3 		$3.92K Hold
153
– – ﹤0.01% 3613
2023
Q2 		$2.64K Sell
153
-1,599
-91% -$24.5K ﹤0.01% 3724
2023
Q1 		$21.3K Buy
1,752
+821
+88% +$34.7K ﹤0.01% 3714
2022
Q4 		$33.2K Buy
931
+17
+2% +$530 ﹤0.01% 3679
2022
Q3 		$31K Sell
914
-349
-28% -$17.4K ﹤0.01% 3700
2022
Q2 		$47K Sell
1,263
-153
-11% -$16.3K ﹤0.01% 3778
2022
Q1 		$217K Sell
1,416
-129
-8% -$26.5K ﹤0.01% 3220
2021
Q4 		$457K Buy
1,545
+137
+10% +$40.2K ﹤0.01% 2905
2021
Q3 		$391K Buy
1,408
+277
+24% +$75.1K ﹤0.01% 3192
2021
Q2 		$310K Buy
1,131
+631
+126% +$226K ﹤0.01% 3524
2021
Q1 		$246K Sell
500
-45
-8% -$32K ﹤0.01% 3520
2020
Q4 		$450K Buy
+545
New +$318K ﹤0.01% 2980

Other funds holding PRAX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Deutsche Bank's PRAX Position: Q3 2026 in Review

Deutsche Bank increased its Praxis Precision Medicines (PRAX) stake by 3.5% in Q3 2026, buying an estimated $752K and bringing the position to 66,536 shares worth $19.4M. The position accounts for 0.01% of the portfolio, ranked #828.

Deutsche Bank first reported a position in PRAX in Q4 2020 and has held it in 24 quarters since. The position peaked at $21.5M in Q2 2026. 113 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Deutsche Bank held 66,536 shares of Praxis Precision Medicines worth $19.4M as of Q3 2026.
  • Deutsche Bank bought 2,273 Praxis Precision Medicines shares in Q3 2026, an estimated $752K.
  • Praxis Precision Medicines made up 0.01% of Deutsche Bank's portfolio in Q3 2026, its #828 holding.
  • Deutsche Bank first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 24 quarters since.
  • Deutsche Bank's Praxis Precision Medicines position peaked at $21.5M in Q2 2026.
  • 113 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.